Development of Molecular Methods for Rapid Differentiation of Mycoplasma gallisepticum Vaccine Strains from Field Isolates

Mycoplasma gallisepticum is among the most economically significant mycoplasmas causing production losses in poultry. Seven melt-curve and agarose gel-based mismatch amplification mutation assays (MAMAs) and one PCR are provided in the present study to distinguish the M. gallisepticum vaccine strains and field isolates based on mutations in the crmA, gapA, lpd, plpA, potC, glpK, and hlp2 genes. ABSTRACT Mycoplasma gallisepticum is among the most economically significant mycoplasmas causing production losses in poultry. Seven melt-curve and agarose gel-based mismatch amplification mutation assays (MAMAs) and one PCR are provided in the present study to distinguish the M. gallisepticum vaccine strains and field isolates based on mutations in the crmA, gapA, lpd, plpA, potC, glpK, and hlp2 genes. A total of 239 samples (M. gallisepticum vaccine and type strains, pure cultures, and clinical samples) originating from 16 countries and from at least eight avian species were submitted to the presented assays for validation or in blind tests. A comparison of the data from 126 samples (including sequences available at GenBank) examined by the developed assays and a recently developed multilocus sequence typing assay showed congruent typing results. The sensitivity of the melt-MAMA assays varied between 101 and 104 M. gallisepticum template copies/reaction, while that of the agarose-MAMAs ranged from 103 to 105 template copies/reaction, and no cross-reactions occurred with other Mycoplasma species colonizing birds. The presented assays are also suitable for discriminating multiple strains in a single sample. The developed assays enable the differentiation of live vaccine strains by targeting two or three markers/vaccine strain; however, considering the high variability of the species, the combined use of all assays is recommended. The suggested combination provides a reliable tool for routine diagnostics due to the sensitivity and specificity of the assays, and they can be performed directly on clinical samples and in laboratories with basic PCR equipment.

[1]  J. Bradbury,et al.  Genotyping Mycoplasma gallisepticum by multilocus sequence typing. , 2019, Veterinary microbiology.

[2]  S. Edwards,et al.  Core Genome Multilocus Sequence Typing: a Standardized Approach for Molecular Typing of Mycoplasma gallisepticum , 2017, Journal of Clinical Microbiology.

[3]  K. Bányai,et al.  Mutations Associated with Decreased Susceptibility to Seven Antimicrobial Families in Field and Laboratory-Derived Mycoplasma bovis Strains , 2016, Antimicrobial Agents and Chemotherapy.

[4]  Saravanaraj N. Ayyampalayam,et al.  Identification of Strain-Specific Sequences That Distinguish a Mycoplasma gallisepticum Vaccine Strain from Field Isolates , 2016, Journal of Clinical Microbiology.

[5]  L. Kőrösi,et al.  Rapid, Simple and Cost-Effective Molecular Method to Differentiate the Temperature Sensitive (ts+) MS-H Vaccine Strain and Wild-Type Mycoplasma synoviae Isolates , 2015, PloS one.

[6]  J. Foster,et al.  First isolation and characterization of Brucella microti from wild boar , 2015, BMC Veterinary Research.

[7]  A. Kanci,et al.  Evaluation of the Capacity of PCR and High-Resolution Melt Curve Analysis for Identification of Mixed Infection with Mycoplasma gallisepticum Strains , 2015, PloS one.

[8]  S. Williams,et al.  The efficacy of Mycoplasma gallisepticum K-strain live vaccine in broiler and layer chickens , 2015, Avian pathology : journal of the W.V.P.A.

[9]  A. Noormohammadi,et al.  Comparison of multiple genes and 16S-23S rRNA intergenic space region for their capacity in high resolution melt curve analysis to differentiate Mycoplasma gallisepticum vaccine strain ts-11 from field strains. , 2013, Veterinary microbiology.

[10]  P. Markham,et al.  MalF is essential for persistence of Mycoplasma gallisepticum in vivo. , 2013, Microbiology.

[11]  L. Stipkovits,et al.  Role of the GapA and CrmA Cytadhesins of Mycoplasma gallisepticum in Promoting Virulence and Host Colonization , 2013, Infection and Immunity.

[12]  E. Tulman,et al.  Extensive variation in surface lipoprotein gene content and genomic changes associated with virulence during evolution of a novel North American house finch epizootic strain of Mycoplasma gallisepticum. , 2012, Microbiology.

[13]  Shane S. Sturrock,et al.  Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data , 2012, Bioinform..

[14]  Dawn N. Birdsell,et al.  Melt Analysis of Mismatch Amplification Mutation Assays (Melt-MAMA): A Functional Study of a Cost-Effective SNP Genotyping Assay in Bacterial Models , 2012, PloS one.

[15]  M. El Gazzar,et al.  Characterization of a ts-11–like Mycoplasma gallisepticum Isolate from Commercial Broiler Chickens , 2011, Avian diseases.

[16]  P. Markham,et al.  Differentiation of Mycoplasma gallisepticum strains using PCR and high-resolution melting curve analysis. , 2010, Microbiology.

[17]  E. Tulman,et al.  Comparative Genomic Analyses of Attenuated Strains of Mycoplasma gallisepticum , 2010, Infection and Immunity.

[18]  S. Kleven,et al.  The Development of Diagnostic Real-Time Taqman PCRs for The Four Pathogenic Avian Mycoplasmas , 2009, Avian diseases.

[19]  J. Stülke,et al.  Glycerol Metabolism Is Important for Cytotoxicity of Mycoplasma pneumoniae , 2008, Journal of bacteriology.

[20]  S. Kleven,et al.  The Development of Diagnostic Real-Time Taqman Pcrs for the Four Pathogenic Avian Mycoplasmas , 2009 .

[21]  S. Kleven.  Control of Avian Mycoplasma Infections in Commercial Poultry , 2008, Avian diseases.

[22]  S. Callison,et al.  Strain differentiating real-time PCR for Mycoplasma gallisepticum live vaccine evaluation studies. , 2008, Veterinary microbiology.

[23]  M. May,et al.  Identification of Fibronectin-Binding Proteins in Mycoplasma gallisepticum Strain R , 2006, Infection and Immunity.

[24]  K. Cecchini,et al.  Identification of a Virulence-Associated Determinant, Dihydrolipoamide Dehydrogenase (lpd), in Mycoplasma gallisepticum through In Vivo Screening of Transposon Mutants , 2006, Infection and Immunity.

[25]  N. Ikuta,et al.  Use of molecular diversity of Mycoplasma gallisepticum by gene-targeted sequencing (GTS) and random amplified polymorphic DNA (RAPD) analysis for epidemiological studies. , 2005, Microbiology.

[26]  P. Savelkoul,et al.  Differentiation of Mycoplasma gallisepticum Strains Using Amplified Fragment Length Polymorphism and Other DNA-Based Typing Methods , 2005, Avian diseases.

[27]  S. Kleven,et al.  Avian mycoplasmosis (Mycoplasma gallisepticum). , 2000, Revue scientifique et technique.

[28]  Turner Ks,et al.  Eradication of live F strain mycoplasma gallisepticum vaccine using live ts-11 on a multiage commercial layer farm. , 1998 .

[29]  S. Kleven,et al.  Pen trial studies on the use of live vaccines to displace virulent Mycoplasma gallisepticum in chickens. , 1998, Avian diseases.

[30]  S. Kleven,et al.  Eradication of live F strain mycoplasma gallisepticum vaccine using live ts-11 on a multiage commercial layer farm. , 1998, Avian diseases.

[31]  K. Whithear.  Control of avian mycoplasmoses by vaccination. , 1996, Revue scientifique et technique.

[32]  M. Jackwood,et al.  Application of polymerase chain reaction with arbitrary primers to strain identification of Mycoplasma gallisepticum. , 1995, Avian diseases.

[33]  L. Lauerman,et al.  Avian mycoplasma identification using polymerase chain reaction amplicon and restriction fragment length polymorphism analysis. , 1995, Avian diseases.

[34]  Evans Rd,et al.  Demonstration of the genetic stability of a Mycoplasma gallisepticum strain following in vivo passage. , 1992 .

[35]  Y. Hafez,et al.  Evaluation of a Mycoplasma gallisepticum strain exhibiting reduced virulence for prevention and control of poultry mycoplasmosis. , 1992, Avian diseases.

[36]  Y. Hafez,et al.  Demonstration of the genetic stability of a Mycoplasma gallisepticum strain following in vivo passage. , 1992, Avian diseases.

[37]  S. Kleven,et al.  Fingerprinting of Mycoplasma gallisepticum strains isolated from multiple-age layers vaccinated with live F strain. , 1990, Avian diseases.

[38]  K. Whithear,et al.  Safety of temperature sensitive mutant Mycoplasma gallisepticum vaccine. , 1990, Australian veterinary journal.

[39]  R. Hanson,et al.  A medium for the isolation of avian mycoplasmas. , 1968, American journal of veterinary research.

[40]  H. Adler,et al.  Characterization of pleuropneumonia-like organisms of avian origin. I. Antigenic analysis of seven strains and their comparative pathogenicity for birds. , 1958, The Journal of infectious diseases.

[41]  H. Adler,et al.  The effect of certain antibiotics and chemical agents on pleuropneumonia-like organisms of avian origin. , 1956, American journal of veterinary research.